4.5 Article

Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy

期刊

EUROPEAN JOURNAL OF HUMAN GENETICS
卷 24, 期 12, 页码 1761-1770

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2016.80

关键词

-

资金

  1. UCB-Pharma France
  2. ANR (Agence Nationale de la Recherche) grant 'EPILAND' [ANR-2010-BLAN-1405 01]
  3. EuroBiomed label
  4. European Union Seventh Framework Programme FP7 [602531]
  5. INSERM
  6. Hospices Civils de Lyon
  7. Lundbeck Foundation [2013-14290]
  8. UCPH Programme for Interdisciplinary Research (Global Genes, Local Concerns)
  9. Danish Council for Independent Research - Medical Sciences [4183-00482B]
  10. Lundbeck Foundation [R151-2013-14290, R13-2007-1172] Funding Source: researchfish

向作者/读者索取更多资源

Genetic generalized epilepsy (GGE), formerly known as idiopathic generalized epilepsy, is the most common form of epilepsy and is thought to have predominant genetic etiology. GGE are clinically characterized by absence, myoclonic, or generalized tonic-clonic seizures with electroencephalographic pattern of bilateral, synchronous, and symmetrical spike-and-wave discharges. Despite their strong heritability, the genetic basis of generalized epilepsies remains largely elusive. Nevertheless, recent advances in genetic technology have led to the identification of numerous genes and genomic defects in various types of epilepsies in the past few years. In the present study, we performed whole-exome sequencing in a family with GGE consistent with the diagnosis of eyelid myoclonia with absences. We found a nonsense variant (c. 196C>T/p.(Arg66*)) in RORB, which encodes the beta retinoid-related orphan nuclear receptor (ROR beta), in four affected family members. In addition, two de novo variants (c.218T>C/p.(Leu73Pro); c. 1249_1251delACG/p.(Thr417del)) were identified in sporadic patients by trio-based exome sequencing. We also found two de novo deletions in patients with behavioral and cognitive impairment and epilepsy: a 52-kb microdeletion involving exons 5-10 of RORB and a larger 9q21-microdeletion. Furthermore, we identified a patient with intellectual disability and a balanced translocation where one breakpoint truncates RORB and refined the phenotype of a recently reported patient with RORB deletion. Our data support the role of RORB gene variants/CNVs in neurodevelopmental disorders including epilepsy, and especially in generalized epilepsies with predominant absence seizures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data

Roberta Celli, Pasquale Striano, Rita Citraro, Luisa Di Menna, Milena Cannella, Tiziana Imbriglio, Mahmoud Koko, Euro Epinomics-Cogie Euro Epinomics-Cogie Consortium, Giovambattista De Sarro, James A. Monn, Giuseppe Battaglia, Gilles van Luijtelaar, Ferdinando Nicoletti, Emilio Russo, Antonio Leo

Summary: Previous studies suggest that modulation of mGlu3 receptors may be a potential treatment for absence epilepsy. This study found that mGlu3 receptor expression and signaling were decreased in the somatosensory cortex and thalamus of epileptic rats, and selective activation of mGlu3 receptors reduced seizures and depressive-like behavior. However, no association was found between genetic variants of GRM3 and absence epilepsy.

CURRENT NEUROPHARMACOLOGY (2023)

Article Clinical Neurology

Conserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes

Tobias Brunger, Eduardo Perez-Palma, Ludovica Montanucci, Michael Nothnagel, Rikke S. Moller, Stephanie Schorge, Sameer Zuberi, Joseph Symonds, Johannes R. Lemke, Andreas Brunklaus, Stephen F. Traynelis, Patrick May, Dennis Lal

Summary: This study aimed to systematically identify biological features associated with variant pathogenicity in ion-channel genes and found that these features are correlated with clinical phenotypes and molecular measurements in patients with neurodevelopmental disorders. The results suggest the feasibility of clinical decision support algorithms that can predict variant pathogenicity and function in the future.
Article Clinical Neurology

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study

Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C. Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail M. Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Shikha Polega, Ronald Davis, Antonio Gil-Nagel

Summary: Long-term use of fenfluramine showed sustained reduction in drop seizure frequency in LGS patients, with significant reduction in the frequency of GTCS and tonic seizures. The drug was generally well tolerated with minimal adverse effects and no significant cardiac side effects observed. Fenfluramine may serve as an important long-term treatment option for patients with LGS.

EPILEPSIA (2023)

Article Biochemistry & Molecular Biology

Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development

Antony Kaspi, Michael S. Hildebrand, Victoria E. Jackson, Ruth Braden, Olivia van Reyk, Tegan Howell, Simone Debono, Mariana Lauretta, Lottie Morison, Matthew J. Coleman, Richard Webster, David Coman, Himanshu Goel, Mathew Wallis, Gabriel Dabscheck, Lilian Downie, Emma K. Baker, Bronwyn Parry-Fielder, Kirrie Ballard, Eva Harrold, Shaun Ziegenfusz, Mark F. Bennett, Erandee Robertson, Longfei Wang, Amber Boys, Simon E. Fisher, David J. Amor, Ingrid E. Scheffer, Melanie Bahlo, Angela T. Morgan

Summary: This study identified new candidate genes associated with childhood apraxia of speech (CAS) through genome sequencing and bioinformatic analysis. The findings highlight the roles of chromatin organization and gene regulation in CAS, and confirm co-expression of CAS-related genes during brain development.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' condition

Helena Martins Custodio, Lisa M. Clayton, Ravishankara Bellampalli, Susanna Pagni, Katri Silvennoinen, Richard Caswell, John C. Ambrose, Andreas Brunklaus, Renzo Guerrini, Bobby P. C. Koeleman, Johannes R. Lemke, Rikke S. Moler, Ingrid E. Scheffer, Sarah Weckhuysen, Federico Zara, Sameer Zuberi, Karoline Kuchenbaecker, Simona Balestrini, James D. Mills, Sanjay M. Sisodiya

Summary: Dravet syndrome, a rare severe epilepsy caused by SCN1A variants, shows phenotypic heterogeneity that cannot be fully explained by the causal variant or clinical factors. In this study, additional genomic variation and rare variants in epilepsy-related genes were found to contribute to the phenotypic diversity of adults with SCN1A-related Dravet syndrome. The study also revealed differences in polygenic risk scores for intelligence and longevity between Dravet syndrome and epilepsy controls, suggesting that genetic background plays a role in the syndrome's phenotype and mortality risk.
Article Clinical Neurology

Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies

Alice M. Donnan, Amy L. Schneider, Sophie Russ-Hall, Leonid Churilov, Ingrid E. Scheffer

Summary: This study aims to describe the proportions of patients with commonly encountered genetic developmental and epileptic encephalopathies (DEEs) who developed convulsive status epilepticus (CSE), nonconvulsive status epilepticus (NCSE), and sudden unexplained death in epilepsy (SUDEP). The findings showed that the proportions of these serious presentations vary for different genetic DEEs. These results have important implications for early diagnosis, management, and disease-specific counseling for this high-risk group of conditions.

NEUROLOGY (2023)

Article Clinical Neurology

Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture

Rebekah V. Harris, Karen L. Oliver, Piero Perucca, Pasquale Striano, Angelo Labate, Antonella Riva, Bronwyn E. Grinton, Joshua Reid, Jessica Hutton, Marian Todaro, Terence J. O'Brien, Patrick Kwan, Lynette G. Sadleir, Saul A. Mullen, Emanuela Dazzo, Douglas E. Crompton, Ingrid E. Scheffer, Melanie Bahlo, Carlo Nobile, Antonio Gambardella, Samuel F. Berkovic

Summary: This study analyzed 134 families with familial mesial temporal lobe epilepsy (FMTLE) and found that FMTLE is a generally mild drug-responsive syndrome with the main symptom being déjà vu. Unlike monogenic focal epilepsy syndromes, molecular data supports a polygenic basis for FMTLE. The polygenic risk score (PRS) data suggests that sub-genome-wide significant focal epilepsy genome-wide association study single nucleotide polymorphisms are important risk variants for FMTLE.

ANNALS OF NEUROLOGY (2023)

Article Biology

Increased prime edit rates in KCNQ2 and SCN1A via single nicking all-in-one plasmids

N. Dirkx, Wout J. J. Weuring, E. De Vriendt, N. Smal, J. van de Vondervoort, Ruben van 't Slot, M. Koetsier, N. Zonnekein, Tim De Pooter, S. Weckhuysen, B. P. C. Koeleman

Summary: This study demonstrates improved editing rates in hiPSC using EF-1 & alpha;-driven sncRNA pAIO-PE plasmids, especially after FACS sorting. Optimizing these sncRNA PE systems will be important for future therapeutic in vivo use, where accuracy is crucial.

BMC BIOLOGY (2023)

Article Clinical Neurology

Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies

Sterre Van der Veen, Gabrielle T. W. Tse, Alessandro Ferretti, Giacomo Garone, Bart Post, Nicola Specchio, Victor S. C. Fung, Marina Trivisano, Ingrid E. Scheffer

Summary: In patients with genetic DEEs, a variety of MDs are present, with stereotypies and dystonia being the most common. Different biological mechanisms may lead to different types of MDs.

NEUROLOGY (2023)

Editorial Material Clinical Neurology

Are Germline Mosaic TSC1/2 Variants Present in Controls? Implications for Diagnosis

Zimeng Ye, Sufang Lin, Xia Zhao, Mathew Wallis, Xinyi Gao, Li Sun, Jiarui Wu, Jing Duan, Yi Yao, Lin Li, Li Chen, Dezhi Cao, Zhanqi Hu, Victor W. Zhang, Samuel F. Berkovic, Ingrid E. Scheffer, Jianxiang Liao, Michael S. Hildebrand

PEDIATRIC NEUROLOGY (2024)

Article Neurosciences

Intrafamilial variability in SLC6A1-related neurodevelopmental disorders

Benedetta Kassabian, Christina Duhring Fenger, Marjolaine Willems, Angel Aledo-Serrano, Tarja Linnankivi, Pamela Pojomovsky McDonnell, Laina Lusk, Birgit Susanne Jepsen, Michael Bayat, Anja Kattentidt, Anna Abuli Vidal, Gabriel Valero-Lopez, Helena Alarcon-Martinez, Kimberly Goodspeed, Marjon van Slegtenhorst, Tahsin Stefan Barakat, Rikke S. Moller, Katrine M. Johannesen, Guido Rubboli

Summary: The phenotypic spectrum of SLC6A1-related neurodevelopmental disorders (SLC6A1-NDD) includes intellectual disability (ID), autistic spectrum disorders (ASD), epilepsy, developmental delay, and other neurological features. Our study aimed to investigate intrafamilial phenotypic variability in families with SLC6A1 variants and found that relatives presented with a less severe phenotype compared to probands.

FRONTIERS IN NEUROSCIENCE (2023)

Correction Neurosciences

Intrafamilial variability in SLC6A1-related neurodevelopmental disorders (vol 17, 1219262, 2023)

Benedetta Kassabian, Christina Duhring Fenger, Marjolaine Willems, Angel Aledo-Serrano, Tarja Linnankivi, Pamela Pojomovsky Mcdonnell, Laina Lusk, Birgit Susanne Jepsen, Michael Bayat, Anja A. Kattentidt-Mouravieva, Anna Abuli Vidal, Gabriel Valero-Lopez, Helena Alarcon-Martinez, Kimberly Goodspeed, Marjon van Slegtenhorst, Tahsin Stefan Barakat, Rikke S. Moller, Katrine M. Johannesen, Guido Rubboli

FRONTIERS IN NEUROSCIENCE (2023)

Article Neurosciences

The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders

Katrine M. Johannesen, Jimmi Nielsen, Anne Sabers, Bertrand Isidor, Anja A. Kattentidt-Mouravieva, Dominik Zieglgaensberger, Alexis R. Heidlebaugh, Kathryn F. Oetjens, Anna Abuli Vidal, Jakob Christensen, Jacob Tiller, Amber N. Freed, Rikke S. Moller, Guido Rubboli

Summary: SLC6A1 is a common genetic cause of epilepsy and neurodevelopmental disorders. Adult patients with SLC6A1 variants show similar phenotypic characteristics to pediatric patients, including intellectual disability, epilepsy, and behavioral disorders.

FRONTIERS IN NEUROSCIENCE (2023)

Correction Clinical Neurology

Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders (vol 143, pg 3564, 2020)

Fanny Mochel, AgnSs Rastetter, Berten Ceulemans, Konrad Platzer, Sandra Yang, Deepali N. Shinde, Katherine L. Helbig, Diego Lopergolo, Francesca Mari, Alessandra Renieri, Elisa Benetti, Roberto Canitano, Quinten Waisfisz, Astrid S. Plomp, Sylvia A. Huisman, Golder N. Wilson, Sara S. Cathey, Raymond J. Louie, Daniela Del Gaudio, Darrel Waggoner, Shawn Kacker, Kimberly M. Nugent, Elizabeth R. Roeder, Ange-Line Bruel, Julien Thevenon, Nadja Ehmke, Denise Horn, Manuel Holtgrewe, Frank J. Kaiser, Susanne B. Kamphausen, Rami Abou Jamra, Sarah Weckhuysen, Carine Dalle, Christel Depienne

Article Medicine, General & Internal

Clinical and electrophysiological features of SCN8A variants causing episodic or chronic ataxia

Hang Lyu, Christian M. Bosselmann, Katrine M. Johannesen, Mahmoud Koko, Juan Dario Ortigoza-Escobar, Sergio Aguilera-Albesa, Deyanira Garcia -Navas Nunez, Tarja Linnankivi, Eija Gaily, Henriette J. A. van Ruiten, Ruth Richardson, Cornelia Betzler, Gabriella Horvath, Eva Brilstra, Niels Geerdink, Daniele Orsucci, Alessandra Tessa, Elena Gardella, Zofia Fleszar, Ludger Schoels, Holger Lerche, Rikke S. Moller, Yuanyuan Liu

Summary: SCN8A variants are associated with a spectrum of ataxias, including chronic progressive and episodic ataxia. Variants causing chronic ataxia exhibit a more pronounced loss-of-function effect, while variants causing episodic ataxia show mixed gain-and loss-of function effects. Sodium channel blockers should be avoided in individuals with SCN8A-related ataxias.

EBIOMEDICINE (2023)

暂无数据